Literature DB >> 9496191

Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism.

J Raza1, P C Hindmarsh, C G Brook.   

Abstract

The rate of fall of serum thyroid stimulating hormone (TSH) concentrations in 32 hypothyroid infants (11 boys, 21 girls) was studied after starting treatment with thyroxine to determine whether it was influenced by initial TSH concentration or the cause of the hypothyroidism. Of 27 patients who had isotope scans before treatment was started, 11 (40%) were athyrotic, 10 (38%) had an ectopic gland, and six (22%) probably had dyshormonogenesis. Treatment was started with thyroxine at 100 micrograms/m2/24 hours at a mean age of 26 days (range 14-45). Serum TSH concentrations remained increased in 26 (81%) at 3 months, 20 (62.5%) at 6 months, and nine (28%) at 1 year and beyond. The mean age for serum TSH to reach the normal range was 0.79 years (range 0.15-2.1 years). Diagnosis (in 27 patients) and initial results (in 32) made no difference to the rate of fall.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496191      PMCID: PMC1717416          DOI: 10.1136/adc.77.6.526

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Monitoring TSH concentrations during treatment for congenital hypothyroidism.

Authors:  D B Grant
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up.

Authors:  A Lucas; R Morley; M S Fewtrell
Journal:  BMJ       Date:  1996-05-04

3.  Long-term effects of L-thyroxine therapy for congenital hypothyroidism.

Authors:  J F Rovet; R M Ehrlich
Journal:  J Pediatr       Date:  1995-03       Impact factor: 4.406

4.  Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism.

Authors:  J A Germak; T P Foley
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

5.  Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine.

Authors:  D B Grant; P W Fuggle; I Smith
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

6.  Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment.

Authors:  J M Dubuis; J Glorieux; F Richer; C L Deal; J H Dussault; G Van Vliet
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

7.  Significance of elevated serum thyrotropin during treatment of congenital hypothyroidism.

Authors:  S Heyerdahl; B F Kase
Journal:  Acta Paediatr       Date:  1995-06       Impact factor: 2.299

8.  Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.

Authors:  S S Abusrewil; L Tyfield; D C Savage
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

9.  Growth, development, and reassessment of hypothyroid infants diagnosed by screening.

Authors:  J A Hulse; D B Grant; D Jackson; B E Clayton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

10.  Thryo-endocrine pathology, obstetric morbidity and schizophrenia: survey of a hundred families with a schizophrenic proband.

Authors:  D MacSweeney; P Timms; A Johnson
Journal:  Psychol Med       Date:  1978-02       Impact factor: 7.723

  10 in total
  1 in total

1.  Optimisation of thyroxine dose in congenital hypothyroidism.

Authors:  P C Hindmarsh
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.